Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells

Oncogene
Y SuminamiT L Whiteside

Abstract

Interleukin-2 (IL-2) is recognized as a T cell growth factor. We have previously reported that human carcinoma cell lines are inhibited in growth by exogenous IL-2, which binds to the IL-2 receptor beta (IL-2Rbeta) chain ubiquitously expressed on the surface of tumor cells. A possibility was considered that IL-2Rbeta on carcinomas responsible for negative signaling was different from that expressed on hematopoietic cells. To investigate this possibility, mRNA for the IL-2Rbeta chain was amplified and compared in carcinoma and lymphoid cells. Using RT-PCR with pairs of sense-antisense oligonucleotide primers specific for the various regions of extracellular, transmembrane and intracellular domains of the IL-2Rbeta chain, we amplified mRNA obtained from three human carcinoma cell lines and human lymphoid cells as controls. The identity of the amplicons was confirmed by Southern analysis with the 32P-labeled cDNA probe coding for the entire span of the IL-2Rbeta chain. In addition, genomic DNA obtained from the tumor cell lines was sequenced to examine the possibility that a mutation is present in the gene coding for the intracellular IL-2Rbeta chain domain. No mutations or deletions were detected. The message for all three domain...Continue Reading

Citations

Dec 10, 2002·Biochemical and Biophysical Research Communications·Patricia H CasanaManuel J Arana
Feb 6, 2003·The American Journal of Chinese Medicine·Sung Ock SuhMin Young Cho
Jan 2, 2013·Journal of Comparative Pathology·A MeyerR Klopfleisch
Oct 31, 2006·Biochemical and Biophysical Research Communications·Yi ShenJian-Hong Luo
Feb 28, 2001·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·S ThikkurissyL Kiremidjian-Schumacher
Jun 16, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Rosario AmatoNicola Perrotti
Nov 11, 1999·British Journal of Cancer·T E ReichertT L Whiteside
Apr 18, 2001·Cell Research·X Q Fan, Y J Guo
Sep 14, 2002·Cancer Control : Journal of the Moffitt Cancer Center·Mayer Fishman, John Seigne
Feb 29, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·D ZellaR C Gallo
Mar 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·V M CorrigallG S Panayi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.